Analyst Ratings for Generate Biomedicines (GENB)
GENB Rating Summary
GENB Price Target Summary
- Highest: $30.00 (Guggenheim)
- Lowest: $22.00 (Morgan Stanley)
- Average: $26.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$26.40 (+67.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/13/2026 | H.C. Wainwright » Updated 8/28/2026 |
Mitchell Kapoor | New Coverage | Buy (N/A) |
30.00 (25.00) |
11.41 (15.79) |
38.39% | Details |
| 3/24/2026 | Cantor Fitzgerald » Updated 4/2/2026 |
Eric Schmidt | New Coverage | Overweight (N/A) |
N/A (N/A) |
12.52 (15.79) |
26.12% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
